Highlights Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
6.42 ^USD	+1.74%		-8.81%	-41.69%

04:03pm	Barclays Upgrades Relay Therapeutics to Overweight From Equalweight With $15 Price Target	MT
05-06	Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M	05-02	MT
Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Relay Therapeutics Q4 Loss Widens, Reports No Revenue	02-23	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
Relay Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22	CI
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q3 Revenue $25.2M	11-02	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
Relay Therapeutics, Inc. Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors	23-10-12	CI
Relay Therapeutics' Q2 Loss Widens	23-08-09	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q2 Revenue $119,000	23-08-08	MT
RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-05-04	AQ
Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Relay Therapeutics, Inc. Announces Initial Clinical Data Demonstrating That Rly-2608 Selectively Targets Multiple PI3KaMutations	23-04-18	CI
Relay Therapeutics' Q4 Loss Narrows, Revenue Falls	23-02-24	MT
RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-02-23	AQ
Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q4 Revenue $253M	23-02-23	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Relay Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-23	CI
RELAY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Highlights

Filters